Attys' Fee Award Cut To $91M In Pfizer Neurontin MDL
A Massachusetts federal judge on Monday awarded $91 million to the plaintiffs attorneys in multidistrict litigation accusing Pfizer Inc. of illegally marketing Neurontin for off-label use, saying the $108 million they...To view the full article, register now.
Already a subscriber? Click here to view full article